Vor reports second quarter 2021 financial results and provides company update

Cambridge, mass., aug. 09, 2021 (globe newswire) -- vor biopharma (nasdaq: vor or the company), a cell and genome engineering company, today reported financial results for the three-month period ended june 30, 2021, and provided a business update.

VOR Ratings Summary

VOR Quant Ranking